IGM Biosciences's market cap is currently $82.66M. The company's EPS TTM is $-3.648; its P/E ratio is ―; IGM Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.13M	$ 1.07M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -6.15M	$ -9.53M	$ -7.72M	$ -3.58M	$ -2.33M
Operating Income	$ -263.46M	$ -227.96M	$ -165.32M	$ -83.28M	$ -44.50M
EBITDA	$ -253.36M	$ -221.88M	$ -157.44M	$ -77.78M	$ -40.80M
Net Income	$ -246.42M	$ -214.25M	$ -160.68M	$ -80.33M	$ -42.54M
Balance Sheet
Cash & Short-Term Investments	$ 337.68M	$ 427.16M	$ 229.54M	$ 366.27M	$ 236.61M
Total Assets	$ 423.41M	$ 513.50M	$ 298.13M	$ 408.63M	$ 261.35M
Total Debt	$ 40.51M	$ 41.17M	$ 28.76M	$ 12.24M	$ 14.73M
Net Debt	$ -72.01M	$ -80.06M	$ -104.58M	$ -228.84M	$ -21.16M
Total Liabilities	$ 220.18M	$ 226.24M	$ 53.22M	$ 26.82M	$ 21.12M
Stockholders' Equity	$ 203.23M	$ -574.83M	$ -353.72M	$ -188.56M	$ -107.20M
Cash Flow
Free Cash Flow	$ -204.61M	$ -16.06M	$ -137.58M	$ -84.81M	$ -47.45M
Operating Cash Flow	$ -192.23M	$ -5.85M	$ -124.34M	$ -67.30M	$ -45.12M
Investing Cash Flow	$ 68.36M	$ -225.64M	$ 14.82M	$ 57.71M	$ -203.24M
Financing Cash Flow	$ 115.07M	$ 219.38M	$ 2.48M	$ 214.78M	$ 282.26M

Currency in USD

IGM Biosciences Earnings and Revenue History

Income Statement >

IGM Biosciences Debt to Assets

Balance Sheet >

IGM Biosciences Cash Flow

Cash Flow >

IGM Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing